The Global Melatonin Market Revealed: Profit Margins, Industry Shifts, and Asias Expanding Manufacturing Might

The global melatonin market has become a high-growth segment within APIs ingredients as demand for sleep-health solutions, chronobiology-enabled therapeutics and related nutraceuticals expands. This report uses the market baseline you provided as the core forecast anchor and combines that brief with public market and price signals, regional production intelligence and recent industry news to produce a pragmatic, investor-oriented brief focused on Asia and Southeast Asia. Melatonin is produced and sold both as an API for pharmaceutical uses and as an active ingredient for functional-food formats; synthetic melatonin currently supplies the bulk of commercial volumes while emerging bio-manufacturing approaches (microbial fermentation / biosynthesis) are beginning to scale.
The global melatonin market size in 2024 is USD 2,031 million and a groing compound annual growth rate at 18,9 %, reaching market size USD 6,714 million by 2031. With an average selling price of USD 80K per ton, the total melatonin sold is 25,387 ton in 2024. The factory gross profit is 25%, which implies to a factory gross profit is at USD 20,000 per ton and cost of goods is at USD 60,000 per ton. The COGS breakdown is raw materials/feedstocks, solvents and reagents, labor and direct processing, energy and utilities, environmental treatment and waste disposal, and allocated fixed overheads. A single line full machine capacity production is around 100 ton per line per year. Downstream demand is concentrated in pharmaceutical and functional food and beverages.
Latest Trends and Technological Developments
Price and availability signals have dominated headlines: melatonin spot and contract prices rose in early 2025 as downstream inventory restocking and sustained supplement demand pushed market tightness (price reporting noted price increases in March 2025). Continued quarterly price volatility was documented through 2025 as producers adjusted terms and as end-market restocking patterns shifted. News coverage and industry commentary in 2024 to 2025 also highlighted two technology trends: first, the scaling of biosynthetic/fermentation routes that can produce melatonin at larger commercial batches (academic and pilot-scale breakthroughs were publicized in 20232024 and industry observers continued to track commercialization in 2024 to 2025); second, increasing regulatory and promotional scrutiny in several markets (including tightened oversight of supplement advertising and digital influencer promotion around 2025) which affects go-to-market tactics for supplement brands and platform sellers. Representative items: melatonin price reports and commentary (March 2025) noting rising global prices; Q4/Dec-2024 regional price snapshots showing elevated USD/MT pricing in major import hubs; and ongoing reporting in 2025 about biosynthetic production routes scaling to commercial batches. These signals together indicate a market where supply adjustments, route innovation and regulatory attention are the three immediate watch items for near-term strategy.

Johnson & Johnson Health and Wellness Solutions purchases 2,000 kilograms of pharmaceutical-grade Melatonin API (Active Pharmaceutical Ingredient) from the German firm DSM Nutritional Products for a total contract value of USD 640,000, equating to USD 320 per kilogram. This bulk procurement is designated for the production of their over-the-counter sleep-aid supplements under various brand labels, ensuring a year's supply of raw material.
The product is utilized as the key active ingredient in the formulation of "Natrol Melatonin Fast Dissolve Tablets," manufactured by Natrol LLC (a part of Aurobindo Pharma USA). For its annual production cycle, Natrol incorporates approximately 500 kilograms of high-purity Melatonin into its manufacturing process. This volume, sourced under a supply agreement worth roughly USD 160,000, is used to produce millions of individual supplement units sold in major retail pharmacies like CVS and Walmart across North America and online platforms globally.
Asia is central to both supply and demand for melatonin. China remains the largest Asia-based manufacturer and exporter, with a significant share of API production capacity and large domestic demand for supplement ingredients and finished formulations. Reports and market trackers place East Asia (and especially China) as a dominant supplier region for melatonin APIs, with contract manufacturing ecosystems that can service global nutraceutical and pharma buyers. India is an accelerating market both as a producer of intermediates and as a growing domestic consumer market for supplements. Across Asia, the combination of lower chemical input costs, mature fine-chemical supply chains and expanding CMO capacity makes the region highly competitive on cost per kilogram while also investing in higher-grade GMP lines for regulated pharma supply. Regional risks include regulatory harmonization differences, export controls, and feedstock/energy cost volatility that can impact margins and delivery lead times.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/sample/5542138

Melatonin by Type:
Pharmaceutical Grade Melatonin

Food Grade Melatonin

Melatonin by Product Category:
Natural Melatonin

Synthetic Melatonin

Melatonin by Market Segment:
Tablets

Capsules

Gummy Candies

Liquid

Others

Melatonin by Usage:
Sleep Cycle Regulation

Stress Relief and Relaxation

Senior Wellness

Others

Melatonin by Dosage:
Micro-dose (5 mg)

Others

Melatonin by Application:

Medical

Others

Global Top 20 Key Companies in the Melatonin Market
Natrol

Pharmavite

Nature's Bounty

Jameison

Rexall Sundown

GNC

Pfizer

Solgar

Biotics Research

Now Food

Neurim Pharmaceuticals

Slenyto

Nature Made

Centrum

Vitafusion

Xiu Zheng

By-Health

Conba Pharm

Meiaojian Biotechnology

Regional Insights
Within Southeast Asia, ASEAN demand is growing driven by rising health-conscious consumers, increasing retail and e-commerce penetration for supplements, and faster adoption of OTC sleep aids. Indonesia one of ASEANs largest consumer markets by population shows expanding retail demand for sleep and wellness supplements, but local manufacturing for high-grade API remains limited compared with China and India; Indonesian players typically source melatonin API from international suppliers and focus on formulation, branding and local distribution. Other ASEAN countries (Thailand, Malaysia, Vietnam, Philippines) exhibit heterogeneous profiles: some have localized formulation/nutraceutical manufacturing and are expanding private-label exports, while others remain net importers. For investors and supply-chain managers, ASEAN provides attractive consumption growth but requires careful supply contracts and quality control protocols because much API sourcing will still be imported and subject to customs/regulatory checks. Sources showing Chinas leadership in East Asian production and market research for Asia market shares back these regional observations.

Key industry challenges include price and supply volatility (short-term tightness can push prices higher and disrupt CPG margins), regulatory uncertainty across jurisdictions (supplement labeling, permissible claims, and advertising enforcement are evolving), quality control and counterfeiting risk for non-GMP product streams, environmental and waste management costs for chemical synthesis (increasingly significant as ESG and decarbonization expectations grow), and concentration risk where a limited number of large suppliers dominate capacity. Additionally, the adoption of new biosynthetic production methods introduces technology-risk and scale-up risk: while promising lower marginal costs and greener footprints, biotech routes require capex, regulatory validation for GMP pharma supply and time to reach stable yields. McKinsey and other life-science industry analyses emphasize that API manufacturing faces intensifying cost of compliance and decarbonization burdens which should be accounted for in long-term cost models.

Buyers and CPG brands should secure multi-sourced supply agreements (mix of contract volumes from China/India plus regional buffer inventory in ASEAN warehouses) and set quality gates that require GMP certificates when intended for regulated uses. Producers should prioritize modular, flexible manufacturing that can pivot between GMP API and non-GMP supplement grades, and consider partnerships or licensing with biosynthesis innovators to lower long-run marginal costs. Investors should treat near-term price cycles as both a revenue opportunity and a signal to stress-test supply chains: assets that combine reliable GMP supply with cost controls and environmental compliance will be more investible. Finally, regulatory monitoring (advertising rules, import tolerances, allowable claims) should be part of any go-to-market diligence because enforcement has increased in several markets in 20242025.

Product Models
Melatonin is a naturally occurring hormone widely used as a supplement to support sleep regulation, circadian rhythm balancing, and antioxidant functions.
Pharmaceutical Grade Melatonin is a high-purity form (typically ≥99%) produced under strict GMP conditions and intended for medical, clinical, and regulated supplement formulations. Notable products include:
Circadin® - Neurim Pharmaceuticals: A controlled-release melatonin tablet used clinically to treat primary insomnia in adults over 55.
Thorne® Melatonin 3 mg - Thorne Research: Clinical-grade melatonin commonly used by healthcare professionals.

Food Grade Melatonin is produced for general nutraceutical, functional food, and beverage applications. Notable products include:
Nature Made® Melatonin 3 mg - Nature Made: Food-grade melatonin tablets designed for occasional sleep support.
Goli® - Goli Nutrition: Lifestyle-focused melatonin combined with botanicals for nighttime relaxation.
ZzzQuil® Pure Zzzs - Procter & Gamble: Non-habit-forming melatonin for mild sleep support.
Puritans Pride® Melatonin - Puritans Pride: Affordable consumer-grade melatonin for general wellness supplementation.
Jamieson® Melatonin Fast Dissolve - Jamieson: Canadian consumer-grade melatonin for easy and quick nighttime use.
Melatonin sits at the intersection of strong demand growth for sleep and wellness products and a supply side that is transitioning through price cycles, route innovation and regulatory tightening. Asia (and China specifically) will remain central to global supply, while ASEAN markets (Indonesia included) represent attractive demand pools that rely heavily on imported API but are growing rapidly in finished-product retail. Investors and corporates that focus on securing quality supply, monitoring regulatory changes, and selectively backing scalable, lower-cost production technologies (including validated biosynthetic routes) will be best positioned to capture the sectors premium growth.

Investor Analysis
This report aggregates market sizing, pricing context, margin mechanics and regional supply/demand positioning (China manufacturing scale, India and ASEAN demand growth). How: investors can use these inputs to build valuation models for asset purchases (CMOs, API plants), to size inventory financing (how many MT of buffer given price volatility), or to assess M&A rationales (vertical integration from API to finished product). Why: the combination of high unit prices, accelerating end-market demand, and technology change (biosynthesis) creates both margin expansion opportunities and execution risk; informed investors who underwrite quality/compliance and who de-risk supply chains can earn outsized returns while avoiding reputational/regulatory pitfalls. In short, the data and trends in this report help investors judge whether to back manufacturing capacity growth, to purchase upstream API assets, or to invest in downstream brands that secure long-term supply.

Request for Pre-Order Enquiry On This Report
https://www.qyresearch.com/customize/5542138

5 Reasons to Buy This Report
You get a market baseline and growth assumption tied to public price signals.
The report synthesizes up-to-date price intelligence and volatility indicators for melatonin API.
It provides Asia and ASEAN regional sourcing and demand insights critical for supply-chain decisions.
It highlights technology shifts (biosynthesis scale-up) and regulatory risks that materially affect valuation and commercial strategy.
The report lists leading suppliers and practical commercial actions (e.g., multi-sourcing, GMP gating, inventory sizing) investors and procurement teams can adopt immediately.
5 Key Questions Answered
What is the market size baseline and assumed growth rate through 2031?
What are realistic reference prices per metric ton and how volatile have they been?
Which regions and countries supply most of the melatonin API and where is demand growing fastest?
What are the main operational and regulatory risks for producers and brands?
How should investors and buyers structure sourcing and capex strategies given price, margin and technology dynamics?
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of the product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Sales, revenue of the product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.

Related Report Recommendation

Global Melatonin Market Research Report 2025
https://www.qyresearch.com/reports/3472555/melatonin
Global Melatonin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
https://www.qyresearch.com/reports/4683094/melatonin
Melatonin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
https://www.qyresearch.com/reports/5541362/melatonin
lobal Melatonin Market Outlook, InDepth Analysis & Forecast to 2031
https://www.qyresearch.com/reports/5542138/melatonin
Global Melatonin API Market Research Report 2025
https://www.qyresearch.com/reports/3784061/melatonin-api
Global Melatonin Market Research Report 2025
https://www.qyresearch.com/reports/4004687/melatonin
Global Melatonin Tablets Market Research Report 2025
https://www.qyresearch.com/reports/4372353/melatonin-tablets
Global Melatonin Capsules Market Research Report 2025
https://www.qyresearch.com/reports/4654584/melatonin-capsules
Global Melatonin for Dogs Market Research Report 2025
https://www.qyresearch.com/reports/4467555/melatonin-for-dogs
Global Melatonin for Sleep Market Research Report 2025
https://www.qyresearch.com/reports/3543894/melatonin-for-sleep

Contact Information:
Tel: +1 626 2952 442 (US) ; +86-1082945717 (China)
+62 896 3769 3166 (Whatsapp)
Email: willyanto@qyresearch.com; global@qyresearch.com
Website: www.qyresearch.com

About QY Research
QY Research has established close partnerships with over 71,000 global leading players. With more than 20,000 industry experts worldwide, we maintain a strong global network to efficiently gather insights and raw data.
Our 36-step verification system ensures the reliability and quality of our data. With over 2 million reports, we have become the world's largest market report vendor. Our global database spans more than 2,000 sources and covers data from most countries, including import and export details.
We have partners in over 160 countries, providing comprehensive coverage of both sales and research networks. A 90% client return rate and long-term cooperation with key partners demonstrate the high level of service and quality QY Research delivers.
More than 30 IPOs and over 5,000 global media outlets and major corporations have used our data, solidifying QY Research as a global leader in data supply. We are committed to delivering services that exceed both client and societal expectations.

This release was published on openPR.